The etodolac methyl ester market is projected to grow from USD 16.8 million in 2025 to USD 26.7 million by 2035, at a CAGR of 4.7%. Purity<99% will dominate with a 0.0% market share, while pharmaceutical intermediates will lead the application segment with a 78.0% share.